EN ISO 13485:2016/A11:2021
(Amendment)Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016)
Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016)
Medizinprodukte - Qualitätsmanagementsysteme - Anforderungen für regulatorische Zwecke (ISO 13485:2016)
Dispositifs médicaux - Systèmes de management de la qualité - Exigences à des fins réglementaires (ISO 13485:2016)
Medicinski pripomočki - Sistemi vodenja kakovosti - Zahteve za zakonodajne namene - Dopolnilo A11 (ISO 13485:2016)
General Information
Relations
Standards Content (Sample)
SLOVENSKI STANDARD
01-december-2021
Medicinski pripomočki - Sistemi vodenja kakovosti - Zahteve za zakonodajne
namene - Dopolnilo A1 (ISO 13485:2016)
Medical devices - Quality management systems - Requirements for regulatory purposes
(ISO 13485:2016)
Medizinprodukte - Qualitätsmanagementsysteme - Anforderungen für regulatorische
Zwecke (ISO 13485:2016)
Dispositifs médicaux - Systèmes de management de la qualité - Exigences à des fins
réglementaires (ISO 13485:2016)
Ta slovenski standard je istoveten z: EN ISO 13485:2016/A11:2021
ICS:
03.100.70 Sistemi vodenja Management systems
11.020.01 Vodenje kakovosti in Quality and environmental
ravnanje z okoljem v management in health care
zdravstvu
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.
EUROPEAN STANDARD
EN ISO 13485:2016/A11
NORME EUROPÉENNE
EUROPÄISCHE NORM
September 2021
ICS 03.100.70; 11.040.01
English version
Medical devices - Quality management systems -
Requirements for regulatory purposes (ISO 13485:2016)
Dispositifs médicaux - Systèmes de management de la Medizinprodukte - Qualitätsmanagementsysteme -
qualité - Exigences à des fins réglementaires (ISO Anforderungen für regulatorische Zwecke (ISO
13485:2016) 13485:2016)
This amendment A11 modifies the European Standard EN ISO 13485:2016; it was approved by CEN on 12 April 2021.
CEN and CENELEC members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for
inclusion of this amendment into the relevant national standard without any alteration. Up-to-date lists and bibliographical
references concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to
any CEN and CENELEC member.
This amendment exists in three official versions (English, French, German). A version in any other language made by translation
under the responsibility of a CEN and CENELEC member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.
CEN and CENELEC members are the national standards bodies and national electrotechnical committees of Austria, Belgium,
Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of North Macedonia, Romania, Serbia,
Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom.
CEN-CENELEC Management Centre:
Rue de la Science 23, B-1040 Brussels
© 2021 CEN/CENELEC All rights of exploitation in any form and by any means Ref. No. EN ISO 13485:2016/A11:2021 E
reserved worldwide for CEN national Members and for
CENELEC Members.
Contents Page
European foreword . 3
Annex ZA (informative) Relationship between this European standard and the
requirements of Regulation (EU) 2017/745 aimed to be covered . 4
Annex ZB (informative) Relationship between this European standard and the
requirements of Regulation (EU) 2017/746 aimed to be covered . 16
European foreword
This document (EN ISO 13485:2016/A11:2021) has been prepared by Technical Committee
CEN/CLC/TC 3 “Quality management and corresponding general aspects for medical devices” the
secretariat of which is held by NEN.
This document amends EN ISO 13485:2016, incorporating corrigenda March 2016, December 2016 and
2018, with a revised European Foreword and European Annexes ZA and ZB.
This Amendment to the European Standard EN ISO 13485:2016 has been prepared under a mandate
given to CEN by the European Commission and the European Free Trade Association, and supports
requirements of EU Regulation(s).
For relationship with EU Regulation(s), see informative Annex ZA, and ZB, which are an integral part of
this document.
Any feedback and questions on this document should be directed to the users’ national standards
body/national committee. A complete listing of these bodies can be found on the CEN websites.
The following referenced documents are indispensable for the application of this document. For undated
references, the edition of the referenced document (including any amendments) listed below applies. For
dated references, only the edition cited applies. However, for any use of this standard within the meaning
of Annex ZA or ZB, the user should always check that any referenced document has not been superseded
and that its relevant contents can still be considered the generally acknowledged state-of-art.
When an IEC or ISO standard is referred to in the ISO standard text, this should be understood as a
normative reference to the corresponding EN standard, if available, and otherwise to the dated version
of the ISO or IEC standard as listed below.
NOTE The way in which these referenced documents are cited in normative requirements determines the
extent (in whole or in part) to which they apply.
Table – Correlation between normative references and dated EN and ISO standards
Normative references Equivalent dated standard
as listed in Clause 2 of the ISO
EN ISO
standard
ISO 9000:2015 EN ISO 9000:2015 ISO 9000:2015
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of North
Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the United
Kingdom.
Annex ZA
(informative)
Relationship between this European standard and the requirements of
Regulation (EU) 2017/745 aimed to be covered
This European standard has been prepared under a Commission’s standardisation request M/575 of
14.4.2021 to provide one voluntary means of conforming to the requirements of Regulation (EU)
2017/745 of 5 April 2017 concerning medical devices [OJ L 117].
Once this standard is cited in the Official Journal of the European Union under that Regulation, compliance
with the normative clauses of this standard given in Tables ZA.1, ZA.2 or ZA.3 confers, within the limits
of the scope of this standard, a presumption of conformity with the corresponding requirements of that
Regulation, and associated EFTA regulations.
This Annex covers the relationship of this European standard with:
• the general obligations of the manufacturer in Article 10 (Table ZA.1); and,
• the quality management system requirements in the conformity assessment annexes (Annexes IX
and XI) (Table ZA.2 and ZA.3 respectively).
EN ISO 13485:2016 is an adoption of an international standard, ISO 13485:2016, which is intended to be
applicable in jurisdictions all over the world. Therefore, it is not the primary goal of ISO 13485:2016 to
cover exactly the European quality management system requirements. Consequently, for all of the quality
management system requirements, conformity is not entirely achieved by complying only with the
requirements specified in EN ISO 13485. Manufacturers and conformity assessment bodies will need to
integrate the quality management system requirements in the applicable European Regulation into the
processes provided by EN ISO 13485. In addition, the European Regulations require the incorporation of
certain processes in the quality management system, such as clinical evaluation, risk management, post-
market surveillance, and assignment of unique device identification. EN ISO 13485 requires the
integration of these processes into the quality management system in accordance with regulatory
requirements but does not explicitly include the details of the particular European Union regulatory
requirements within the standard. Furthermore, the definitions in applicable regulatory requirements
differ from nation to nation and region to region. As a result, the definitions in this document can differ
in wording from those in European Regulations. For use in support of European requirements, definitions
in the European regulations for medical devices take precedence.
In addition to requirements on the manufacturer’s quality management system, Article 10 and
Annexes IX and XI of the European Regulations include a description of the regulatory processes and
activities undertaken by the notified body, competent authority and European Commission, which are
outside of the scope of EN ISO 13485 and therefore not covered by the standard.
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the risk
management process needs to be in compliance with Regulation (EU) 2017/745. This means that risks have to be
‘reduced as far as possible’, ‘reduced to the lowest possible level’, ‘reduced as far as possible and appropriate’,
‘removed or reduced as far as possible’, ‘eliminated or reduced as far as possible’, ’removed or minimized as far as
possible’, or ‘minimized’, according to the wording of the corresponding General Safety and Performance
Requirement.
NOTE 2 The manufacturer’s policy for determining acceptable risk must be in compliance with General Safety
and Performance Requirements 1, 2, 3, 4, 5, 8, 9, 10, 11, 14, 16, 17, 18, 19, 20, 21 and 22 of the Regulation.
NOTE 3 This Annex ZA is based on normative references according to the table of references in the European
Foreword, replacing the references in the core text.
NOTE 4 When a requirement does not appear in Tables ZA.1, ZA.2 or ZA.3 it means that it is not addressed by
this European Standard.
Table ZA.1 – Correspondence between this European standard and the requirements of Article 10 of
Regulation (EU) 2017/745 [OJ L 117]
Requirements of Article 10 Clause(s) / sub-clause(s) of
Remarks / Notes
of Regulation (EU) 2017/745 this EN
1 4.1, 7.1, 7.2.1 c), 7.2.2 c), 7.3, 7.5 Partially covered. EN ISO 13485 includes
requirements for the QMS, design and
development and manufacturing that
require incorporation of the regulatory
requirements into the quality
management system.
2 7.1 Partially covered. EN ISO 13485 includes
requirements to risk management in
product realization. The detail of the
specific requirements of Annex 1,
Chapter 1 of the Regulation is not stated
explicitly.
3 Not covered. 7.3.7 of EN ISO 13485
requires clinical evaluation in
accordance with applicable regulatory
requirements. The details contained in
Article 61 or Annex XIV are not provided.
st
4, 1 paragraph 4.2.3 Partially covered. EN ISO 13485 requires
that the quality management system
includes one or more files either
containing or referencing documents
generated to demonstrate compliance
with applicable regulatory requirements.
A summary of the types of documents is
provided. All the detail in Annexes II and
III is not provided explicitly.
nd
4, 2 paragraph Not covered. Refers to action by the
European Commission outside the scope
of the standard.
5 4.2.3 Partially covered. EN ISO 13485 requires
that the quality management system
includes one or more files either
containing or referencing documents
generated to demonstrate compliance
with applicable regulatory requirements.
A summary of the types of documents is
provided. All the detail in Annex XIII is
not provided explicitly.
6 Not covered. Preparation of the EU
declaration of conformity is not covered
in EN ISO 13485
7 Not covered. 7.5.8 of EN ISO 13485
includes a requirement to control the
Requirements of Article 10 Clause(s) / sub-clause(s) of
Remarks / Notes
of Regulation (EU) 2017/745 this EN
UDI under the quality management
system. The detail of the system
prescribed in Article 27, and with the
registration obligations referred to in
Articles 29 and 31, are not provided.
st
8, 1 paragraph 4.2.4, 4.2.5, 7.2.3 Partially covered. EN ISO 13485 requires
the retention of documents, including
records, for at least the period specified
by applicable regulatory requirements.
The retention time defined in the
Regulations is not provided explicitly.
nd
8, 2 paragraph 7.2.3 Partially covered. EN ISO 13485 requires
communication with regulatory
authorities in accordance with
applicable regulatory requirements. The
term ‘regulatory authorities’ is used in a
general context and the term competent
authority, as used in the Regulation, is
not explicitly mentioned. The provision
of specific information as detailed in the
Regulation is not stated explicitly.
rd
8, 3 paragraph Not covered.
st st
9, 1 paragraph, 1 sentence 4, 5, 6, 7, 8 Covered. EN ISO 13485 requires the
quality management system to comply
with applicable regulatory requirements
and that production is planned, carried
out, monitored and controlled to ensure
that product conforms to specification
and regulatory requirements.
st nd
9, 1 paragraph, 2 sentence 4.1.4, 4.2.4, 5.6.2, 5.6.3, 7.3.3, Partially covered. EN ISO 13485 includes
7.3.9 general reference to regulatory
requirements and standards as design
and development inputs. Identification
of new or revised regulatory
requirements is identified as an input
into Management Review) and changes
needed as a result of such changes
required as outputs of Management
Review). Change to the medical device is
covered through control of design and
development changes. Common
specifications are not explicitly
mentioned.
rd
9, 1st paragraph, 3 sentence 4.1 Partially covered. EN ISO 13485 requires
that the effectiveness of the quality
management system is maintained and
provides requirements for improvement
processes, including corrective action
and preventive action. There is no
explicit require
...
SLOVENSKI STANDARD
01-december-2021
Medicinski pripomočki - Sistemi vodenja kakovosti - Zahteve za zakonodajne
namene - Dopolnilo A11 (ISO 13485:2016)
Medical devices - Quality management systems - Requirements for regulatory purposes
(ISO 13485:2016)
Medizinprodukte - Qualitätsmanagementsysteme - Anforderungen für regulatorische
Zwecke (ISO 13485:2016)
Dispositifs médicaux - Systèmes de management de la qualité - Exigences à des fins
réglementaires (ISO 13485:2016)
Ta slovenski standard je istoveten z: EN ISO 13485:2016/A11:2021
ICS:
03.100.70 Sistemi vodenja Management systems
11.020.01 Vodenje kakovosti in Quality and environmental
ravnanje z okoljem v management in health care
zdravstvu
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.
EUROPEAN STANDARD
EN ISO 13485:2016/A11
NORME EUROPÉENNE
EUROPÄISCHE NORM
September 2021
ICS 03.100.70; 11.040.01
English version
Medical devices - Quality management systems -
Requirements for regulatory purposes (ISO 13485:2016)
Dispositifs médicaux - Systèmes de management de la Medizinprodukte - Qualitätsmanagementsysteme -
qualité - Exigences à des fins réglementaires (ISO Anforderungen für regulatorische Zwecke (ISO
13485:2016) 13485:2016)
This amendment A11 modifies the European Standard EN ISO 13485:2016; it was approved by CEN on 12 April 2021.
CEN and CENELEC members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for
inclusion of this amendment into the relevant national standard without any alteration. Up-to-date lists and bibliographical
references concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to
any CEN and CENELEC member.
This amendment exists in three official versions (English, French, German). A version in any other language made by translation
under the responsibility of a CEN and CENELEC member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.
CEN and CENELEC members are the national standards bodies and national electrotechnical committees of Austria, Belgium,
Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of North Macedonia, Romania, Serbia,
Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom.
CEN-CENELEC Management Centre:
Rue de la Science 23, B-1040 Brussels
© 2021 CEN/CENELEC All rights of exploitation in any form and by any means Ref. No. EN ISO 13485:2016/A11:2021 E
reserved worldwide for CEN national Members and for
CENELEC Members.
Contents Page
European foreword . 3
Annex ZA (informative) Relationship between this European standard and the
requirements of Regulation (EU) 2017/745 aimed to be covered . 4
Annex ZB (informative) Relationship between this European standard and the
requirements of Regulation (EU) 2017/746 aimed to be covered . 16
European foreword
This document (EN ISO 13485:2016/A11:2021) has been prepared by Technical Committee
CEN/CLC/TC 3 “Quality management and corresponding general aspects for medical devices” the
secretariat of which is held by NEN.
This document amends EN ISO 13485:2016, incorporating corrigenda March 2016, December 2016 and
2018, with a revised European Foreword and European Annexes ZA and ZB.
This Amendment to the European Standard EN ISO 13485:2016 has been prepared under a mandate
given to CEN by the European Commission and the European Free Trade Association, and supports
requirements of EU Regulation(s).
For relationship with EU Regulation(s), see informative Annex ZA, and ZB, which are an integral part of
this document.
Any feedback and questions on this document should be directed to the users’ national standards
body/national committee. A complete listing of these bodies can be found on the CEN websites.
The following referenced documents are indispensable for the application of this document. For undated
references, the edition of the referenced document (including any amendments) listed below applies. For
dated references, only the edition cited applies. However, for any use of this standard within the meaning
of Annex ZA or ZB, the user should always check that any referenced document has not been superseded
and that its relevant contents can still be considered the generally acknowledged state-of-art.
When an IEC or ISO standard is referred to in the ISO standard text, this should be understood as a
normative reference to the corresponding EN standard, if available, and otherwise to the dated version
of the ISO or IEC standard as listed below.
NOTE The way in which these referenced documents are cited in normative requirements determines the
extent (in whole or in part) to which they apply.
Table – Correlation between normative references and dated EN and ISO standards
Normative references Equivalent dated standard
as listed in Clause 2 of the ISO
EN ISO
standard
ISO 9000:2015 EN ISO 9000:2015 ISO 9000:2015
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of North
Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the United
Kingdom.
Annex ZA
(informative)
Relationship between this European standard and the requirements of
Regulation (EU) 2017/745 aimed to be covered
This European standard has been prepared under a Commission’s standardisation request M/575 of
14.4.2021 to provide one voluntary means of conforming to the requirements of Regulation (EU)
2017/745 of 5 April 2017 concerning medical devices [OJ L 117].
Once this standard is cited in the Official Journal of the European Union under that Regulation, compliance
with the normative clauses of this standard given in Tables ZA.1, ZA.2 or ZA.3 confers, within the limits
of the scope of this standard, a presumption of conformity with the corresponding requirements of that
Regulation, and associated EFTA regulations.
This Annex covers the relationship of this European standard with:
• the general obligations of the manufacturer in Article 10 (Table ZA.1); and,
• the quality management system requirements in the conformity assessment annexes (Annexes IX
and XI) (Table ZA.2 and ZA.3 respectively).
EN ISO 13485:2016 is an adoption of an international standard, ISO 13485:2016, which is intended to be
applicable in jurisdictions all over the world. Therefore, it is not the primary goal of ISO 13485:2016 to
cover exactly the European quality management system requirements. Consequently, for all of the quality
management system requirements, conformity is not entirely achieved by complying only with the
requirements specified in EN ISO 13485. Manufacturers and conformity assessment bodies will need to
integrate the quality management system requirements in the applicable European Regulation into the
processes provided by EN ISO 13485. In addition, the European Regulations require the incorporation of
certain processes in the quality management system, such as clinical evaluation, risk management, post-
market surveillance, and assignment of unique device identification. EN ISO 13485 requires the
integration of these processes into the quality management system in accordance with regulatory
requirements but does not explicitly include the details of the particular European Union regulatory
requirements within the standard. Furthermore, the definitions in applicable regulatory requirements
differ from nation to nation and region to region. As a result, the definitions in this document can differ
in wording from those in European Regulations. For use in support of European requirements, definitions
in the European regulations for medical devices take precedence.
In addition to requirements on the manufacturer’s quality management system, Article 10 and
Annexes IX and XI of the European Regulations include a description of the regulatory processes and
activities undertaken by the notified body, competent authority and European Commission, which are
outside of the scope of EN ISO 13485 and therefore not covered by the standard.
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the risk
management process needs to be in compliance with Regulation (EU) 2017/745. This means that risks have to be
‘reduced as far as possible’, ‘reduced to the lowest possible level’, ‘reduced as far as possible and appropriate’,
‘removed or reduced as far as possible’, ‘eliminated or reduced as far as possible’, ’removed or minimized as far as
possible’, or ‘minimized’, according to the wording of the corresponding General Safety and Performance
Requirement.
NOTE 2 The manufacturer’s policy for determining acceptable risk must be in compliance with General Safety
and Performance Requirements 1, 2, 3, 4, 5, 8, 9, 10, 11, 14, 16, 17, 18, 19, 20, 21 and 22 of the Regulation.
NOTE 3 This Annex ZA is based on normative references according to the table of references in the European
Foreword, replacing the references in the core text.
NOTE 4 When a requirement does not appear in Tables ZA.1, ZA.2 or ZA.3 it means that it is not addressed by
this European Standard.
Table ZA.1 – Correspondence between this European standard and the requirements of Article 10 of
Regulation (EU) 2017/745 [OJ L 117]
Requirements of Article 10 Clause(s) / sub-clause(s) of
Remarks / Notes
of Regulation (EU) 2017/745 this EN
1 4.1, 7.1, 7.2.1 c), 7.2.2 c), 7.3, 7.5 Partially covered. EN ISO 13485 includes
requirements for the QMS, design and
development and manufacturing that
require incorporation of the regulatory
requirements into the quality
management system.
2 7.1 Partially covered. EN ISO 13485 includes
requirements to risk management in
product realization. The detail of the
specific requirements of Annex 1,
Chapter 1 of the Regulation is not stated
explicitly.
3 Not covered. 7.3.7 of EN ISO 13485
requires clinical evaluation in
accordance with applicable regulatory
requirements. The details contained in
Article 61 or Annex XIV are not provided.
st
4, 1 paragraph 4.2.3 Partially covered. EN ISO 13485 requires
that the quality management system
includes one or more files either
containing or referencing documents
generated to demonstrate compliance
with applicable regulatory requirements.
A summary of the types of documents is
provided. All the detail in Annexes II and
III is not provided explicitly.
nd
4, 2 paragraph Not covered. Refers to action by the
European Commission outside the scope
of the standard.
5 4.2.3 Partially covered. EN ISO 13485 requires
that the quality management system
includes one or more files either
containing or referencing documents
generated to demonstrate compliance
with applicable regulatory requirements.
A summary of the types of documents is
provided. All the detail in Annex XIII is
not provided explicitly.
6 Not covered. Preparation of the EU
declaration of conformity is not covered
in EN ISO 13485
7 Not covered. 7.5.8 of EN ISO 13485
includes a requirement to control the
Requirements of Article 10 Clause(s) / sub-clause(s) of
Remarks / Notes
of Regulation (EU) 2017/745 this EN
UDI under the quality management
system. The detail of the system
prescribed in Article 27, and with the
registration obligations referred to in
Articles 29 and 31, are not provided.
st
8, 1 paragraph 4.2.4, 4.2.5, 7.2.3 Partially covered. EN ISO 13485 requires
the retention of documents, including
records, for at least the period specified
by applicable regulatory requirements.
The retention time defined in the
Regulations is not provided explicitly.
nd
8, 2 paragraph 7.2.3 Partially covered. EN ISO 13485 requires
communication with regulatory
authorities in accordance with
applicable regulatory requirements. The
term ‘regulatory authorities’ is used in a
general context and the term competent
authority, as used in the Regulation, is
not explicitly mentioned. The provision
of specific information as detailed in the
Regulation is not stated explicitly.
rd
8, 3 paragraph Not covered.
st st
9, 1 paragraph, 1 sentence 4, 5, 6, 7, 8 Covered. EN ISO 13485 requires the
quality management system to comply
with applicable regulatory requirements
and that production is planned, carried
out, monitored and controlled to ensure
that product conforms to specification
and regulatory requirements.
st nd
9, 1 paragraph, 2 sentence 4.1.4, 4.2.4, 5.6.2, 5.6.3, 7.3.3, Partially covered. EN ISO 13485 includes
7.3.9 general reference to regulatory
requirements and standards as design
and development inputs. Identification
of new or revised regulatory
requirements is identified as an input
into Management Review) and changes
needed as a result of such changes
required as outputs of Management
Review). Change to the medical device is
covered through control of design and
development changes. Common
specifications are not explicitly
mentioned.
rd
9, 1st paragraph, 3 sentence 4.1 Partially covered. EN ISO 13485 requires
that the effectiveness of the quality
management system is maintained and
provides requirements for improvement
processes, including corrective action
and preventive action. There is no
explicit requir
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.